JP2007526917A - Ｈｍ７４のオキシデカヒドロナフタレンモジュレーター - Google Patents

Ｈｍ７４のオキシデカヒドロナフタレンモジュレーター Download PDF

Info

Publication number
JP2007526917A
JP2007526917A JP2006554127A JP2006554127A JP2007526917A JP 2007526917 A JP2007526917 A JP 2007526917A JP 2006554127 A JP2006554127 A JP 2006554127A JP 2006554127 A JP2006554127 A JP 2006554127A JP 2007526917 A JP2007526917 A JP 2007526917A
Authority
JP
Japan
Prior art keywords
substituted
combination
branched
contain
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006554127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526917A5 (https=
Inventor
アン・ミニク
テリーザ・クンツワイラー
ハイフェング・アイシングドレロ
マイクル・アンジェラストロ
シュテファン・ヘンケ
Original Assignee
アベンティス・ファーマスーティカルズ・インコーポレイテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アベンティス・ファーマスーティカルズ・インコーポレイテツド filed Critical アベンティス・ファーマスーティカルズ・インコーポレイテツド
Publication of JP2007526917A publication Critical patent/JP2007526917A/ja
Publication of JP2007526917A5 publication Critical patent/JP2007526917A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
JP2006554127A 2004-02-20 2005-02-10 Ｈｍ７４のオキシデカヒドロナフタレンモジュレーター Pending JP2007526917A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54601204P 2004-02-20 2004-02-20
PCT/US2005/004095 WO2005082352A1 (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74

Publications (2)

Publication Number Publication Date
JP2007526917A true JP2007526917A (ja) 2007-09-20
JP2007526917A5 JP2007526917A5 (https=) 2008-03-21

Family

ID=34910747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006554127A Pending JP2007526917A (ja) 2004-02-20 2005-02-10 Ｈｍ７４のオキシデカヒドロナフタレンモジュレーター

Country Status (21)

Country Link
US (2) US7264937B2 (https=)
EP (1) EP1718293A1 (https=)
JP (1) JP2007526917A (https=)
KR (1) KR101145693B1 (https=)
CN (1) CN1929833A (https=)
AR (1) AR047708A1 (https=)
AU (1) AU2005216878B2 (https=)
BR (1) BRPI0507916A (https=)
CA (1) CA2556757C (https=)
CR (1) CR8537A (https=)
EC (1) ECSP066776A (https=)
IL (1) IL177106A (https=)
MA (1) MA28368A1 (https=)
ME (2) MEP17008A (https=)
NO (1) NO20064214L (https=)
RS (1) RS20060472A (https=)
RU (1) RU2006133539A (https=)
TN (1) TNSN06235A1 (https=)
TW (1) TWI354552B (https=)
WO (1) WO2005082352A1 (https=)
ZA (1) ZA200606687B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083388A2 (en) * 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
CN101115726A (zh) 2004-12-03 2008-01-30 先灵公司 作为cb1拮抗剂的取代哌嗪
AR059021A1 (es) * 2006-01-18 2008-03-05 Schering Corp Moduladores de receptores cannabinoides
US20100197564A1 (en) * 2007-04-19 2010-08-05 Schering Corporation Diaryl morpholines as cb1 modulators
US8623873B2 (en) * 2007-06-28 2014-01-07 Intervet Inc. Substituted piperazines as CB1 antagonists
US20100286160A1 (en) * 2007-06-28 2010-11-11 Intervet Inc. Substituted piperazines as cb1 antagonists

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000512305A (ja) * 1996-06-18 2000-09-19 ヘキスト・アクチエンゲゼルシヤフト 環縮合したジヒドロピラン類、その製造方法およびその使用
WO2002018938A1 (en) * 2000-09-01 2002-03-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
JP2002508660A (ja) * 1997-06-12 2002-03-19 スミスクライン ビーチャム コーポレーション Ｈｍ７４ａ受容体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5674908A (en) * 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000512305A (ja) * 1996-06-18 2000-09-19 ヘキスト・アクチエンゲゼルシヤフト 環縮合したジヒドロピラン類、その製造方法およびその使用
JP2002508660A (ja) * 1997-06-12 2002-03-19 スミスクライン ビーチャム コーポレーション Ｈｍ７４ａ受容体
WO2002018938A1 (en) * 2000-09-01 2002-03-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
RS20060472A (sr) 2008-11-28
MEP17008A (hr) 2010-06-10
IL177106A (en) 2012-03-29
RU2006133539A (ru) 2008-03-27
AR047708A1 (es) 2006-02-08
AU2005216878A1 (en) 2005-09-09
CR8537A (es) 2007-03-05
CN1929833A (zh) 2007-03-14
CA2556757C (en) 2011-05-03
TWI354552B (en) 2011-12-21
NO20064214L (no) 2006-09-18
ECSP066776A (es) 2006-11-16
US20080045586A1 (en) 2008-02-21
WO2005082352A1 (en) 2005-09-09
US7264937B2 (en) 2007-09-04
CA2556757A1 (en) 2005-09-09
ME00059B (me) 2010-06-10
EP1718293A1 (en) 2006-11-08
IL177106A0 (en) 2006-12-10
TW200539864A (en) 2005-12-16
ZA200606687B (en) 2008-02-27
US20050187263A1 (en) 2005-08-25
KR20060127982A (ko) 2006-12-13
AU2005216878B2 (en) 2010-06-17
KR101145693B1 (ko) 2012-05-25
BRPI0507916A (pt) 2007-07-10
TNSN06235A1 (en) 2007-12-03
MA28368A1 (fr) 2006-12-01

Similar Documents

Publication Publication Date Title
US7556931B2 (en) Furosemide modulators of HM74
US7173118B2 (en) Nogo receptor homologs
EP2567698B1 (en) GPR 17 agonists and screening assay
US20080045586A1 (en) Oxydecahydronaphthalene modulators of hm74
JPWO2006118328A1 (ja) 脱顆粒抑制剤
MXPA06009413A (en) Oxydecahydronaphthalene modulators of hm74
JP4772684B2 (ja) スクリーニング方法
US7442767B2 (en) α1D calcium channel expressed in atrium
HK1098681A (en) Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110607

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111108